Olanzapine Withdrawn Phase 3 Trials for Schizoaffective Disorders / Schizophrenia Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00440843Zyprexa and Task Engagement in Schizophrenia